Borregaard ASA (BRRDF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Borregaard ASA (BRRDF) with AI Score 50/100 (Hold). Borregaard ASA specializes in developing, producing, and marketing advanced biomaterials, biochemicals, and biofuels. Market cap: 0, Sector: Basic materials.
Last analyzed: Mar 15, 2026Borregaard ASA (BRRDF) Materials & Commodity Exposure
Borregaard ASA is a global leader in sustainable biomaterials, biochemicals, and biofuels, operating through three segments: BioSolutions, BioMaterials, and Fine Chemicals. The company distinguishes itself by converting natural resources into specialized products for diverse industries, including agrochemicals, construction, and the food and beverage sector, with a focus on innovation and environmental responsibility.
Investment Thesis
Borregaard ASA presents a compelling investment case based on its focus on sustainable biomaterials and biochemicals, aligning with increasing global demand for eco-friendly products. With a market capitalization of $1.91 billion and a P/E ratio of 27.52, the company demonstrates solid financial performance. A key value driver is the increasing adoption of biopolymers and specialty cellulose in various industries, driven by environmental regulations and consumer preferences. Growth catalysts include expansion into new geographic markets and the development of innovative applications for its existing product lines. However, potential risks include fluctuations in raw material prices and competition from traditional chemical producers. The company's dividend yield of 2.49% offers an additional incentive for investors.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $1.91B reflecting investor confidence in Borregaard's market position.
- P/E Ratio of 27.52 indicating a premium valuation compared to the broader market, driven by growth expectations.
- Profit Margin of 8.0% demonstrating effective cost management and operational efficiency.
- Gross Margin of 20.4% showcasing the value-added nature of Borregaard's specialized products.
- Dividend Yield of 2.49% providing a steady income stream for investors.
Competitors & Peers
Strengths
- Integrated biorefinery operations.
- Focus on sustainable biomaterials.
- Strong market position in specialty cellulose.
- Diversified product portfolio.
Weaknesses
- Exposure to raw material price fluctuations.
- Limited geographic diversification.
- Dependence on specific customer segments.
- Relatively small scale compared to major chemical companies.
Catalysts
- Ongoing: Increasing demand for sustainable biomaterials driven by environmental regulations.
- Upcoming: Potential expansion into new geographic markets in Asia and South America by 2027.
- Ongoing: Development of new applications for specialty cellulose in industrial applications.
- Upcoming: Launch of new fine chemical intermediates for contrast agents in Q4 2026.
- Ongoing: Strategic partnerships and acquisitions to expand product portfolio.
Risks
- Potential: Fluctuations in raw material prices affecting profitability.
- Ongoing: Competition from established chemical producers with greater scale.
- Potential: Changes in environmental regulations impacting production costs.
- Ongoing: Economic downturns reducing demand for industrial products.
- Potential: Technological disruptions in biomaterials production.
Growth Opportunities
- Expansion of BioSolutions Segment: The BioSolutions segment, which provides biopolymers and biovanillin, has significant growth potential due to increasing demand for sustainable alternatives in agrochemicals, batteries, and the food and beverage industry. The global biopolymers market is projected to reach $10 billion by 2028, offering Borregaard a substantial opportunity to increase its market share through product innovation and strategic partnerships.
- Penetration of the Cellulose Fibrils Market: Borregaard's BioMaterials segment can capitalize on the growing demand for cellulose fibrils in industrial applications. The cellulose fibrils market is expected to grow as industries seek sustainable and high-performance materials. Borregaard can leverage its expertise in specialty cellulose to develop new applications and expand its customer base.
- Geographic Expansion in Asia: Borregaard has the opportunity to expand its presence in the Asian market, where demand for biomaterials and biochemicals is rapidly increasing. By establishing local production facilities or strategic alliances, Borregaard can better serve Asian customers and capitalize on the region's growth potential. This expansion could significantly boost revenue within the next 3-5 years.
- Development of New Fine Chemical Intermediates: The Fine Chemicals segment can drive growth by developing new fine chemical intermediates for contrast agents and other specialized applications. By investing in research and development, Borregaard can create innovative products that meet the evolving needs of its customers and capture new market opportunities. This includes bioethanol production enhancements.
- Strategic Partnerships and Acquisitions: Borregaard can accelerate its growth by forming strategic partnerships or acquiring companies with complementary technologies or market access. These partnerships can enable Borregaard to expand its product portfolio, enter new markets, and enhance its competitive position. Potential targets could include companies specializing in bioprocessing or sustainable materials.
Opportunities
- Expansion into new geographic markets.
- Development of new applications for existing products.
- Strategic partnerships and acquisitions.
- Increasing demand for sustainable materials.
Threats
- Competition from traditional chemical producers.
- Changes in environmental regulations.
- Economic downturns affecting industrial demand.
- Technological disruptions in biomaterials production.
Competitive Advantages
- Integrated Biorefinery Model: Borregaard's integrated biorefinery model provides a cost advantage and reduces reliance on external suppliers.
- Specialized Product Portfolio: The company's focus on specialized biomaterials and biochemicals creates a niche market with less competition.
- Strong Customer Relationships: Borregaard's long-standing relationships with key customers provide a stable revenue stream.
- Sustainable Solutions: The increasing demand for sustainable products gives Borregaard a competitive edge over traditional chemical producers.
About BRRDF
Borregaard ASA, established in 2012 and headquartered in Sarpsborg, Norway, is a prominent developer, producer, and marketer of specialized biomaterials, biochemicals, and biofuels. The company operates across Norway, Europe, the United States, and Asia, serving a global clientele. Borregaard's business is structured into three core segments: BioSolutions, BioMaterials, and Fine Chemicals. The BioSolutions segment provides biopolymers for applications in agrochemicals, batteries, industrial binders, and construction, as well as biovanillin for the flavor and fragrance industries and the food and beverage sector. The BioMaterials segment focuses on specialty cellulose, a raw material used in the production of cellulose ethers, cellulose acetate, and cellulose fibrils for industrial applications. The Fine Chemicals segment produces fine chemical intermediates for contrast agents and bioethanol. Borregaard's commitment to sustainability and innovation positions it as a key player in the evolving landscape of specialty chemicals and biomaterials.
What They Do
- Develops specialized biomaterials from natural resources.
- Produces biochemicals for various industrial applications.
- Markets biofuels as a sustainable energy alternative.
- Offers biopolymers for agrochemicals, batteries, and construction.
- Provides biovanillin for the flavor and fragrance industries.
- Supplies specialty cellulose for cellulose ethers and acetate.
- Produces cellulose fibrils for industrial applications.
- Manufactures fine chemical intermediates for contrast agents and bioethanol.
Business Model
- Borregaard utilizes an integrated biorefinery model, converting natural resources into a range of specialized products.
- The company generates revenue through the sale of biomaterials, biochemicals, and biofuels to various industries.
- Borregaard focuses on high-value applications and customized solutions to meet specific customer needs.
- The company invests in research and development to innovate new products and improve existing processes.
Industry Context
Borregaard ASA operates within the specialty chemicals industry, which is experiencing growth driven by the increasing demand for sustainable and bio-based materials. The global specialty chemicals market is projected to reach hundreds of billions of dollars in the coming years, fueled by applications in various sectors such as construction, food, and pharmaceuticals. Borregaard's focus on biomaterials and biochemicals positions it favorably within this landscape, as companies and consumers seek alternatives to traditional petrochemical-based products. Competitors include companies like AlzChem Group AG (ALZCF) and Celanese Corporation (CSNVF), but Borregaard differentiates itself through its integrated biorefinery model and focus on high-value applications.
Key Customers
- Agrochemical companies requiring biopolymers.
- Battery manufacturers using biopolymers for enhanced performance.
- Construction companies utilizing industrial binders.
- Flavor and fragrance companies sourcing biovanillin.
- Food and beverage companies incorporating biovanillin.
- Manufacturers of cellulose ethers and acetate.
Financials
Chart & Info
Borregaard ASA (BRRDF) stock price: Price data unavailable
Latest News
-
Borregaard ASA: Notice of Borregaard’s Annual General Meeting 2026
Yahoo! Finance: BRRDF News · Mar 26, 2026
-
Borregaard ASA (BRGAY) Discusses Outlook for BioSolutions and BioMaterials, Market Trends, and Volume Expectations Transcript
seekingalpha.com · Mar 19, 2026
-
Borregaard ASA (OTCMKTS:BRRDF) Short Interest Up 27.3% in February
defenseworld.net · Mar 3, 2026
-
Borregaard ASA: Issuance of Commercial Paper
GlobeNewswire · Feb 10, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for BRRDF.
Price Targets
Wall Street price target analysis for BRRDF.
MoonshotScore
What does this score mean?
The MoonshotScore rates BRRDF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
Borregaard ASA: Notice of Borregaard’s Annual General Meeting 2026
Borregaard ASA (BRGAY) Discusses Outlook for BioSolutions and BioMaterials, Market Trends, and Volume Expectations Transcript
Borregaard ASA (OTCMKTS:BRRDF) Short Interest Up 27.3% in February
Borregaard ASA: Issuance of Commercial Paper
Leadership: Tom Erik Foss-Jacobsen
CEO
Tom Erik Foss-Jacobsen serves as the CEO of Borregaard ASA, leading a workforce of 1174 employees. His career spans various leadership roles within the chemical and materials industry. He brings extensive experience in strategic management, operational excellence, and business development. Foss-Jacobsen's background includes a strong focus on driving innovation and sustainability within the organization. His expertise is pivotal in guiding Borregaard's growth and market positioning.
Track Record: Since assuming the role of CEO, Tom Erik Foss-Jacobsen has focused on expanding Borregaard's global reach and enhancing its product portfolio. Key achievements include overseeing the development of new biomaterial applications and strengthening strategic partnerships. He has also emphasized sustainability initiatives, aligning the company's operations with environmental best practices. His leadership has contributed to Borregaard's continued growth and market leadership.
BRRDF OTC Market Information
The OTC Other tier represents the lowest tier of over-the-counter (OTC) markets, indicating that Borregaard ASA (BRRDF) may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited regulatory oversight and may not provide comprehensive financial disclosures, which increases investment risk compared to companies listed on major exchanges like the NYSE or NASDAQ. Investors should exercise caution and conduct thorough due diligence before investing in OTC Other securities.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases the risk of investing in BRRDF.
- Lower liquidity can lead to price volatility and trading difficulties.
- The OTC Other tier indicates a higher risk of fraud or mismanagement.
- Lack of regulatory oversight may expose investors to potential risks.
- Currency exchange rate fluctuations between USD and NOK.
- Verify the company's registration and legal status.
- Obtain and review available financial statements and disclosures.
- Assess the company's management team and their track record.
- Understand the company's business model and competitive landscape.
- Evaluate the company's compliance with environmental regulations.
- Monitor news and press releases for any updates or developments.
- Consult with a financial advisor to assess the risks and potential rewards.
- Borregaard ASA is an established company with a long operating history.
- The company has a diversified product portfolio and serves multiple industries.
- Borregaard is committed to sustainability and environmental responsibility.
- The company has a dedicated management team with industry experience.
- Borregaard pays a dividend, indicating financial stability.
Common Questions About BRRDF
What does Borregaard ASA do?
Borregaard ASA develops, produces, and markets specialized biomaterials, biochemicals, and biofuels. The company operates through three segments: BioSolutions, BioMaterials, and Fine Chemicals. These segments cater to diverse industries, including agrochemicals, construction, food and beverage, and pharmaceuticals. Borregaard's integrated biorefinery model allows it to convert natural resources into high-value products, positioning it as a key player in the sustainable materials market. The company's focus on innovation and environmental responsibility drives its growth and market leadership.
What do analysts say about BRRDF stock?
Analyst coverage of BRRDF stock is limited due to its OTC listing. However, the company's focus on sustainable biomaterials and biochemicals is generally viewed positively, given the increasing demand for eco-friendly products. Key valuation metrics include the P/E ratio of 27.52 and a dividend yield of 2.49%. Growth considerations involve the company's ability to expand into new markets and develop innovative applications for its existing product lines. Investors should conduct their own due diligence and consider the risks associated with OTC-listed securities.
What are the main risks for BRRDF?
The main risks for BRRDF include fluctuations in raw material prices, competition from established chemical producers, and changes in environmental regulations. As a specialty chemical company, Borregaard is exposed to the volatility of raw material costs, which can impact its profitability. Competition from larger chemical companies with greater economies of scale poses a challenge. Additionally, changes in environmental regulations could increase compliance costs and affect the company's operations. Investors should carefully assess these risks before investing in BRRDF.
How does Borregaard ASA compare to competitors in its industry?
Borregaard ASA differentiates itself from competitors like AlzChem Group AG (ALZCF) and Celanese Corporation (CSNVF) through its integrated biorefinery model and focus on sustainable biomaterials. While competitors may offer similar chemical products, Borregaard's commitment to converting natural resources into high-value, eco-friendly materials sets it apart. This focus on sustainability aligns with increasing consumer and regulatory demand for environmentally responsible solutions, providing Borregaard with a competitive advantage in the specialty chemicals market.
What are the key financial metrics investors watch for BRRDF?
Key financial metrics for Borregaard ASA include its market capitalization of $1.91 billion, P/E ratio of 27.52, profit margin of 8.0%, and gross margin of 20.4%. Investors also monitor the company's dividend yield of 2.49% as an indicator of financial stability and shareholder returns. Revenue growth and operating cash flow are important metrics for assessing the company's ability to generate sustainable earnings. Given its focus on sustainable materials, investors also consider metrics related to environmental impact and social responsibility.
What are the key factors to evaluate for BRRDF?
Borregaard ASA (BRRDF) currently holds an AI score of 50/100, indicating moderate score. Key strength: Integrated biorefinery operations.. Primary risk to monitor: Potential: Fluctuations in raw material prices affecting profitability.. This is not financial advice.
How frequently does BRRDF data refresh on this page?
BRRDF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven BRRDF's recent stock price performance?
Recent price movement in Borregaard ASA (BRRDF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Integrated biorefinery operations.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Analyst coverage is limited due to the company's OTC listing.
- Financial data is based on available information and may be subject to change.
- OTC market investments carry higher risks than exchange-listed securities.